Cohance Lifesciences shares surged over 43% in two days following the appointment of former Cipla CEO Umang Vohra as Executive Chairman and Group CEO. Vohra, with over three decades of experience, will lead the company's transformation and growth journey. His expertise is expected to bolster Cohance's differentiated presence in the global CDMO market.